Ignite Creation Date:
2025-12-24 @ 7:21 PM
Ignite Modification Date:
2026-01-03 @ 10:58 PM
Study NCT ID:
NCT04521803
Status:
RECRUITING
Last Update Posted:
2025-08-21
First Post:
2020-07-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
High vs. Standard Dose Rifampicin for Effusive Tuberculous Pericarditis
Sponsor:
University of Cape Town
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
IMPI-3 DMID 20-0007
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None